Press releases

14
Dec 2020
20:48 E.S.T.

Cellectis Announces Launch of Follow-On Offering

Read more
5
Dec 2020
22:00 E.S.T.

Cellectis Reports Preliminary Results from its Phase 1 BALLI-01 Study of UCART22 in R/R Adult B-ALL at American Society of Hematology (ASH) Annual Meeting

Read more
17
Nov 2020
23:58 E.S.T.

FDA Lifts Clinical Hold on MELANI-01 Study Evaluating Cellectis’ Product Candidate UCARTCS1 in Multiple Myeloma

Read more
16
Nov 2020
21:30 E.S.T.

Cellectis Appoints Pharma HR Leader Kyung Nam-Wortman as Executive Vice President, Chief Human Resources Officer

Read more
5
Nov 2020
21:30 E.S.T.

Cellectis Provides Business Update and Reports Financial Results for Third Quarter and First Nine Months 2020

Read more
4
Nov 2020
05:00 E.S.T.

American Society of Hematology (ASH) Abstract Shows Initial Anti-Leukemic Activity of UCART22 in BALLI-01 Phase 1 Study in R/R Adult B-ALL

Read more
21
Oct 2020
20:30 E.S.T.

Cellectis to Hold Third Quarter 2020 Earnings Call on Friday, November 6, 2020 at 8:00AM EST

Read more
16
Oct 2020
12:15 E.S.T.

Calyxt Announces $15 Million Registered Direct Offering

Read more
2
Sep 2020
20:30 E.S.T.

Cellectis to Participate in Upcoming Investor Conferences

Read more
5
Aug 2020
20:30 E.S.T.

Cellectis Provides Business Update and Reports Financial Results for Second Quarter and First Six Months 2020

Read more

Press contacts

For more information on any story, or for press enquiries, get in touch with our communication team

CONTACT US